Literature DB >> 16849443

Cutting edge: lupus susceptibility interval Sle3/5 confers responsiveness to prolactin in C57BL/6 mice.

Elena Peeva1, Juana Gonzalez, Ruthmarie Hicks, Betty Diamond.   

Abstract

Prolactin is of interest in the pathogenesis of systemic lupus erythematosus (SLE) because almost 25% of SLE patients display hyperprolactinemia, and serum prolactin correlates with disease activity in some patients. Furthermore, hyperprolactinemia causes early mortality in lupus-prone mice and induces a lupus-like phenotype in nonspontaneously autoimmune mice. We show here that the immunomodulatory effects of prolactin are genetically determined; hyperprolactinemia breaks B cell tolerance and causes a lupus-like serology in BALB/c mice expressing a transgene encoding the H chain of an anti-DNA Ab but not in C57BL/6 transgenic mice. In C57BL/6 mice that express both the H chain transgene and the lupus susceptibility interval Sle3/5, prolactin induces increased serum titers of anti-DNA Ab and glomerular Ig depositions. The increase in costimulation due to prolactin-mediated up-regulation of both CD40 on B cells and CD40L on T cells would appear to play a central role in lupus induction in this model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849443     DOI: 10.4049/jimmunol.177.3.1401

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Meta-analysis of associations between functional prolactin -1149 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Clin Rheumatol       Date:  2015-02-28       Impact factor: 2.980

Review 2.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population.

Authors:  Yang Xiang; Jing Guo; You-Fan Peng; Hua-Tuo Huang; Yan Lan; Ye-Sheng Wei
Journal:  Rheumatol Int       Date:  2017-05-26       Impact factor: 2.631

Review 4.  Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.

Authors:  Subhrajit Saha; Arlene Tieng; K Peter Pepeljugoski; Gisele Zandamn-Goddard; Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

5.  Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice.

Authors:  J Gonzalez; S Saha; E Peeva
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

6.  Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1 B cells after prolactin treatment.

Authors:  Yadira Ledesma-Soto; Francisco Blanco-Favela; Ezequiel M Fuentes-Pananá; Emiliano Tesoro-Cruz; Rafael Hernández-González; Lourdes Arriaga-Pizano; María V Legorreta-Haquet; Eduardo Montoya-Diaz; Luis Chávez-Sánchez; María E Castro-Mussot; Adriana K Chávez-Rueda
Journal:  BMC Immunol       Date:  2012-03-09       Impact factor: 3.615

7.  Prolactin levels correlate with abnormal B cell maturation in MRL and MRL/lpr mouse models of systemic lupus erythematosus-like disease.

Authors:  Maria Victoria Legorreta-Haquet; Rocio Flores-Fernández; Francisco Blanco-Favela; Ezequiel M Fuentes-Pananá; Luis Chávez-Sánchez; Rafael Hernández-González; Emiliano Tesoro-Cruz; Lourdes Arriaga-Pizano; Adriana Karina Chávez-Rueda
Journal:  Clin Dev Immunol       Date:  2013-12-10

Review 8.  Prolactin: Friend or Foe in Central Nervous System Autoimmune Inflammation?

Authors:  Massimo Costanza; Rosetta Pedotti
Journal:  Int J Mol Sci       Date:  2016-12-02       Impact factor: 5.923

9.  A diversity outbred F1 mouse model identifies host-intrinsic genetic regulators of response to immune checkpoint inhibitors.

Authors:  Justin B Hackett; James E Glassbrook; Maria C Muñiz; Madeline Bross; Abigail Fielder; Gregory Dyson; Nasrin Movahhedin; Jennifer McCasland; Claire McCarthy-Leo; Heather M Gibson
Journal:  Oncoimmunology       Date:  2022-04-20       Impact factor: 7.723

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.